Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes (Q40275970)

19 September 2017

title

Hypertension and Atrial Fibrillation: An Intimate Association of Epidemiology, Pathophysiology, and Outcomes (English)

1 reference

19 September 2017

1 reference

1 reference

4

Gregory Y H Lip

1 reference

19 September 2017

3

Alena Shantsila

1 reference

19 September 2017

2

Farhan Shahid

1 reference

19 September 2017

Mikhail S Dzeshka

1

1 reference

19 September 2017

language of work or name

1 reference

18 February 2017

1 reference

Journal of Clinical Hypertension

19 September 2017

published in

1 reference

19 September 2017

volume

30

1 reference

19 September 2017

issue

8

1 reference

19 September 2017

page(s)

733-755

1 reference

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

19 September 2017

cites work

1 reference

Lone atrial fibrillation: does it exist?

21 January 2018

1 reference

Lone atrial fibrillation - an overview

21 January 2018

1 reference

Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study).

21 January 2018

1 reference

Atrial fibrillation and arterial hypertension: A common duet with dangerous consequences where the renin angiotensin-aldosterone system plays an important role.

21 January 2018

1 reference

The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms

21 January 2018

1 reference

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association

21 January 2018

1 reference

Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.

21 January 2018

1 reference

From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century

21 January 2018

1 reference

50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study

21 January 2018

1 reference

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.

21 January 2018

1 reference

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

21 January 2018

1 reference

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study

21 January 2018

1 reference

The changing circumstance of atrial fibrillation - progress towards precision medicine

21 January 2018

1 reference

The Epidemiology of Atrial Fibrillation and Stroke.

21 January 2018

1 reference

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence

21 January 2018

1 reference

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

21 January 2018

1 reference

Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study

21 January 2018

1 reference

Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial

21 January 2018

1 reference

Atrial fibrillation--the growing epidemic

21 January 2018

1 reference

Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.

21 January 2018

1 reference

Association of Plasma Transforming Growth Factor-β1 Levels and the Risk of Atrial Fibrillation: A Meta-Analysis

21 January 2018

1 reference

Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.

21 January 2018

1 reference

Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences

21 January 2018

1 reference

The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis

21 January 2018

1 reference

Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression

21 January 2018

1 reference

Atrial autonomic innervation: a target for interventional antiarrhythmic therapy?

21 January 2018

1 reference

Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing-induced congestive heart failure.

21 January 2018

1 reference

Vagal atrial fibrillation: What is it and should we treat it?

21 January 2018

1 reference

Local Renin Angiotensin Aldosterone Systems and Cardiovascular Diseases

21 January 2018

1 reference

The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome

21 January 2018

1 reference

Renal denervation for treatment of cardiac arrhythmias: state of the art and future directions

21 January 2018

1 reference

Short-term hypertension is associated with the development of atrial fibrillation substrate: a study in an ovine hypertensive model.

21 January 2018

1 reference

Relations of Arterial Stiffness and Brachial Flow-Mediated Dilation With New-Onset Atrial Fibrillation: The Framingham Heart Study

21 January 2018

1 reference

Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010.

21 January 2018

1 reference

Elevated left ventricular filling pressure estimated by E/E' ratio after exercise predicts development of new-onset atrial fibrillation independently of left atrial enlargement among elderly patients without obvious myocardial ischemia

21 January 2018

1 reference

Atrial Fibrillation and Cardiovascular Outcomes in the Elderly

21 January 2018

1 reference

Mortality associated to atrial fibrillation still on the rise: United States, 1999 to 2014.

21 January 2018

1 reference

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

21 January 2018

1 reference

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis

21 January 2018

1 reference

Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials.

21 January 2018

1 reference

Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.

21 January 2018

1 reference

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

21 January 2018

1 reference

Stroke and bleeding risk in atrial fibrillation: navigating the alphabet soup of risk-score acronyms (CHADS2 , CHA2 DS2 -VASc, R2 CHADS2 , HAS-BLED, ATRIA, and more).

21 January 2018

1 reference

Specific risk scores for specific purposes: use CHA2DS2-VASc for assessing stroke risk, and use HAS-BLED for assessing bleeding risk in atrial fibrillation

21 January 2018

1 reference

Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.

21 January 2018

1 reference

Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation

21 January 2018

1 reference

A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.

21 January 2018

1 reference

Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation

21 January 2018

1 reference

Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score

21 January 2018

1 reference

Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists

21 January 2018

1 reference

Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study.

21 January 2018

1 reference

Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis

21 January 2018

1 reference

Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation: systematic review and meta-analysis

21 January 2018

1 reference

Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review

21 January 2018

1 reference

Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study.

21 January 2018

1 reference

Lone atrial fibrillation as a positive predictor of left atrial volume reduction following ablation of atrial fibrillation

21 January 2018

1 reference

Acute safety outcomes in younger and older patients with atrial fibrillation treated with catheter ablation.

21 January 2018

1 reference

Influence of left ventricular remodeling on atrial fibrillation recurrence and cardiovascular hospitalizations in patients undergoing rhythm-control therapy

21 January 2018

1 reference

Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis

21 January 2018

1 reference

Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy

21 January 2018

1 reference

HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter

21 January 2018

1 reference

Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score

21 January 2018

1 reference

Predicting atrial fibrillation ablation outcome: The CAAP-AF score

21 January 2018

1 reference

Inflammation as a risk factor for atrial fibrillation

21 January 2018

1 reference

A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study).

21 January 2018

1 reference

Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women

21 January 2018

1 reference

European ancestry as a risk factor for atrial fibrillation in African Americans

21 January 2018

1 reference

Pulse pressure and risk of new-onset atrial fibrillation

21 January 2018

1 reference

Palpitations are predictive of future atrial fibrillation. An 11-year follow-up of 22,815 men and women: the Tromsø Study

21 January 2018

1 reference

Relation of Risk of Atrial Fibrillation With Systolic Blood Pressure Response During Exercise Stress Testing (from the Henry Ford ExercIse Testing Project).

21 January 2018

1 reference

Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients

21 January 2018

1 reference

Relation of systolic, diastolic, and pulse pressures and aortic distensibility with atrial fibrillation (from the Multi-Ethnic Study of Atherosclerosis)

21 January 2018

1 reference

Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men.

21 January 2018

1 reference

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

21 January 2018

1 reference

Incidence and Risk Factors for Atrial Fibrillation in Korea: the National Health Insurance Service Database (2002-2010)

21 January 2018

1 reference

Blood pressure control and risk of incident atrial fibrillation.

21 January 2018

1 reference

Atrial fibrillation in hypertension: predictors and outcome

21 January 2018

1 reference

Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands

21 January 2018

1 reference

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

21 January 2018

1 reference

Catheter-based renal sympathetic denervation significantly inhibits atrial fibrillation induced by electrical stimulation of the left stellate ganglion and rapid atrial pacing

21 January 2018

1 reference

Renal denervation suppresses atrial fibrillation in a model of renal impairment

21 January 2018

1 reference

Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation.

21 January 2018

1 reference

Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea

21 January 2018

1 reference

Effect of renal sympathetic denervation on atrial substrate remodeling in ambulatory canines with prolonged atrial pacing

21 January 2018

1 reference

Effect of renal sympathetic denervation on the progression of paroxysmal atrial fibrillation in canines with long-term intermittent atrial pacing.

21 January 2018

1 reference

Renal Denervation Suppresses the Inducibility of Atrial Fibrillation in a Rabbit Model for Atrial Fibrosis

21 January 2018

1 reference

Renal sympathetic denervation suppresses atrial fibrillation induced by acute atrial ischemia/infarction through inhibition of cardiac sympathetic activity.

21 January 2018

1 reference

Reverse cardiac remodeling after renal denervation: Atrial electrophysiologic and structural changes associated with blood pressure lowering.

21 January 2018

1 reference

Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience

21 January 2018

1 reference

Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.

21 January 2018

1 reference

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

21 January 2018

1 reference

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

21 January 2018

1 reference

Delayed recurrence of atrial fibrillation 2years after catheter ablation is associated with metabolic syndrome.

21 January 2018

1 reference

Left atrial sphericity: a new method to assess atrial remodeling. Impact on the outcome of atrial fibrillation ablation.

21 January 2018

1 reference

Association of quality of life, anxiety, and depression with left atrial ablation outcomes

21 January 2018

1 reference

Association Between Plaque Thickness of the Thoracic Aorta and Recurrence of Atrial Fibrillation After Ablation

21 January 2018

1 reference

Does a blanking period after pulmonary vein isolation impact long-term results? Results after 55 months of follow-up.

21 January 2018

1 reference

Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction

21 January 2018

1 reference

Left atrial size and function by three-dimensional echocardiography to predict arrhythmia recurrence after first and repeated ablation of atrial fibrillation

21 January 2018

1 reference

Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation

21 January 2018

1 reference

Prolonged PR interval predicts clinical recurrence of atrial fibrillation after catheter ablation.

21 January 2018

1 reference

Poor scar formation after ablation is associated with atrial fibrillation recurrence

21 January 2018

1 reference

Incidence and risk factors for very late recurrence of atrial fibrillation after radiofrequency catheter ablation

21 January 2018

1 reference

Renin-angiotensin system inhibitors can suppress atrial fibrillation recurrence after encircling ipsilateral pulmonary vein isolation in patients with a non-dilated left atrium

21 January 2018

1 reference

Five-year efficacy of pulmonary vein antrum isolation as a primary ablation strategy for atrial fibrillation: a single-centre cohort study

21 January 2018

1 reference

Upper Normal Blood Pressures Predict Incident Atrial Fibrillation in Healthy Middle-Aged Men

21 January 2018

1 reference

Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNto

21 January 2018

1 reference

Catheter-Based Renal Denervation Reduces Atrial Nerve Sprouting and Complexity of Atrial Fibrillation in Goats

21 January 2018

1 reference

Screening to identify unknown atrial fibrillation

21 January 2018

1 reference

Inducibility of Atrial Fibrillation and Flutter Following Pulmonary Vein Ablation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1093/AJH/HPX013

1 reference

19 September 2017

1 reference